NeoGenomics: 2Q Earnings Snapshot
FORT MYERS, Fla. (AP) _ NeoGenomics Inc. (NEO) on Tuesday reported a loss of $380,000 in its second quarter.
The Fort Myers, Florida-based company said it had a loss of 7 cents per share. Earnings, adjusted for one-time gains and costs, were 5 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 4 cents per share.
The operator of cancer-focused testing laboratories posted revenue of $67.7 million in the period.
NeoGenomics expects full-year earnings in the range of 12 cents to 17 cents per share, with revenue in the range of $260 million to $272 million.
NeoGenomics shares have risen 58 percent since the beginning of the year. The stock has increased 54 percent in the last 12 months.